Confirmation of Portfolio Management Arrangements

Summary by AI BETAClose X

The Biotech Growth Trust PLC confirms that its portfolio management arrangements remain unchanged, with Geoff Hsu continuing as lead portfolio manager and Josh Golomb as co-portfolio manager, supported by the OrbiMed team. This confirmation follows an announcement by Worldwide Healthcare Trust PLC regarding its own management changes. The company's board expressed confidence in the existing management to deliver the investment objective of providing shareholders with exposure to opportunities in the global biotech sector.

Disclaimer*

                    3 August 2026

 

The Biotech Growth Trust PLC

(the "Company")

Confirmation of Portfolio Management Arrangements

The Board of the Company notes the announcement by Worldwide Healthcare Trust PLC regarding changes to its portfolio management arrangements and confirms that there is no change to the Company's portfolio management arrangements. Geoff Hsu remains lead portfolio manager of the Company, supported by Josh Golomb as co-portfolio manager.

Roger Yates, Chair, commented: "The Biotech Growth Trust will maintain its focus on providing shareholders with exposure to the exciting opportunities in the global biotech sector and the Board is confident that Geoff, Josh and the wider team at OrbiMed are well placed to deliver the Company's investment objective."

 

Katherine Manson

Frostrow Capital LLP, Company Secretary

Telephone: 020 3709 8734

 

 




UK 100